Flavay® is the product—used in the actual experiments—by
which
Dr. Jack Masquelier established and perfected the
Radical Scavenger Effect.
Examine the more 60 years of research for
Flavay® is totally safe to use;
a 100% non-toxic and natural—but powerfully effective—nutritional
supplement. Flavay® is a highly specialized, nutritional
complex of pairs and triples of a specific molecule called "flavan-3-ol,"
isolated from natural extracts, that has been extensively tested
and examined clinically for biological antioxidant protection,
collagen strengthening, tissue rebuilding, and other health
producing outcomes.
For more than 60 years this antioxidant complex, now known
as Flavay®, has produced stunning health results across
Europe. The benefits of Flavay® are particularly compelling
because they address so many diverse body tissues and conditions.
Below is an overview of Flavay’s® proven health benefits:
Acts as a superior antioxidant by preventing and fighting
the harmful effects of rampaging free radicals in the body.
Regenerates other antioxidants in the body after they have
quenched free radicals, thereby vastly extending their unique
antioxidant powers and helping the body to maintains its natural
antioxidant balance.
Helps to regulate nitric oxide—one of the newest good-bad
free radicals to demand the scientific spotlight—as it
normalizes blood circulation, helps coordinate activity between
the brain and immune system, modulates communication between
brain cells and is thereby deeply involved in concentration,
learning and memory.
Promotes heart health.
Reduces platelet aggregation.
Increases the strength and elasticity of blood vessels,
protecting against rupture, leakage and degeneration.
Enhances the ability of collagen to repair itself.
Inhibits swelling (edema) and inflammation.
Accelerates recovery time from strenuous games and workouts.
Relieves functional problems associated with varicose veins.
Reduces the tendency toward diabetic retinopathy.
Improves skin health by strengthening and rebuilding the
body's collagen proteins.
Helps prevent the degradation of collagen and elastin, thereby
helping to enhance the elasticity of the skin and offset visible
signs of premature aging.
Supports and protects the body during stressful times.
What is Flavay®?
Flavay® is more than a single nutrient. It is a very specific,
standardized and isolated, singular polyphenol complex defined
and perfected by Dr. Jack Masquelier in France; validated by
the French Ministry of Health and documented by a library of
research consisting of many patents and hundreds of scientific
papers, articles, doctorate theses, lectures and presentations.
Flavay® is not a simple bioflavonoid (this is important
because many are non-bioavailable or even toxic). Flavay®
is comprised of pairs and triples of a specific molecule called,
“flavan-3-ol.” This highly defined, polyphenol complex
is proven fully bioavailable, safe and effective by numerous
human studies, manufactured in France and used worldwide since
1950.
"Radical Scavenger Effect"
of Flavay®
Originally licensed in France for therapeutic uses, Flavay®,
is now available as an antioxidant here in the United States. Flavay®
is the product—used in the actual experiments—by which
Dr. Jack Masquelier established and perfected the "radical
scavenger effect."
"[A] method for preventing and fighting the
harmful biological effects of free radicals in the
organism of warm blooded animals and more especially human
beings, namely cerebral involution, hypoxia following atherosclerosis,
cardiac or cerebral infarction, tumour promotion, inflammation,
ischaemia, alterations of the synovial liquid, collagen
degradation, among others. The method consists in administering
to said animals and especially to human beings an amount,
efficient against said effects, of a plant extract with
a proanthocyanidins content which has a radical scavenger
effect"—Dr. Jack Masquelier, 1987.
Method of Action
Considerable research has demonstrated that Flavay®
has several key actions when consumed:
Flavay® is a powerfully effective ANTIOXIDANT
that recycles other antioxidants in the body after they
have quenched corrosive free radicals which affect many
tissues and conditions including cognitive impairment
and premature aging.
Flavay® helps to regulate the good-bad free
radical, NITRIC OXIDE, which is essential for: normal
blood circulation, coordinating activity between the
immune system and the brain, and modulating communication
between brain cells—and is thereby deeply involved
in concentration, learning and memory.
Flavay® inhibits the release and synthesis of
HISTAMINE, a key factor in the promotion of INFLAMMATION;
reactions associated with conditions like vascular diseases,
allergies, and arthritis.
Flavay® strengthens and rebuilds COLLAGEN proteins,
improving skin and blood vessel health.
Free Radicals: Both Foe and
Friend
Contemporary scientific studies in neurology and immunology
have demonstrated that the body's own immune system has the
ability to damage healthy cells. When the body's immune system
mobilizes, our cells produce by-products called oxygen free
radicals, like pellets of poison, that go to work to destroy
invaders by interfering with their cellular machinery, literally
dissolving or breaking down the genetic material of bacteria,
toxins, and viruses.
When all is going well, the immune system is capable of identifying
foreign invaders such as viruses and bacteria. If functioning
properly, our immune components do not turn against our own
body's cells. Unfortunately, free radicals can interfere with
the biological components of our healthy cells just as they
destroy invaders, literally dismantling the body's essential
cellular proteins, fatty cell membranes and DNA.
The most important natural defenses we have against free radical
damage are our body's natural "antioxidants," a broad
range of chemical substances that all have one thing in common:
they ward off free radical damage to cells. However, in many
neurological diseases—including Parkinson's, Alzheimer's,
chronic fatigue, and multiple sclerosis—the brain's specialized
antioxidant mechanisms fail. The cause of the failure might
be genetic, environmental, or even dietary, but the consequences
are the same: unchecked free radical activity on the brain.
The excessive production of one free radical in particular,
nitric oxide, can be blamed for throwing the brain-immune systems
off kilter and causing some of the brain's worst free radical
damage. Over the past decade, scientists have shown that the
overproduction of nitric oxide through a combination of immune
and nervous system activity— often sparked by an infection,
exposure to a toxin, or as part of the aging process—plays
a key role in the development of neurological diseases.
Antioxidants:
Your Best Weapon Against Toxic Free Radicals
Antioxidants can neutralize free radical attacks and are especially
important as we age. During any challenge to your immune system—because
of disease, infections, toxic exposure, stress or aging—you
need extra antioxidants to help scavenge the free radicals naturally
produced by the immune system's cells during warfare.
Until recently, scientists believed that each antioxidant worked
separately in the body, independently of the others. We now
know that isn't true. Current research demonstrates that key
antioxidants and their co-factor nutrients work synergistically
with one another in the body. Antioxidants work together in
the body—not alone.
Superior Antioxidant Support
Flavay® is superior to other antioxidants because its
protective effects are multiplied in the body: while it provides
its own, powerful antioxidant protection, it also supports the
dynamic interplay between other antioxidants in the body. Flavay’s®
ability to “recycle,” or regenerate vitamins C and
E after they have quenched free radicals vastly extends their
unique antioxidant powers, helping the body to maintain its
synergistic antioxidant balance.
Flavay® is rapidly absorbed and very quickly distributed
throughout the body. As a free radical fighter, Flavay®
comes to the aid of the body more quickly than other antioxidants,
reducing the potential for free radical damage and the ravages
of aging. Flavay® also possesses more reactive sites for
neutralizing free radicals than other known antioxidants. Furthermore,
Flavay® permits reactivity with both positively and negatively
charged free radical species. What this means is that Flavay®
can “quench” or “scavenge” (neutralize)
a broad variety of free radicals. Highly reactive as an antioxidant
in both lipid (fat) and aqueous (water) phases, Flavay®
neutralizes oxygen free radicals and is a valuable protector
of healthy cells in a variety of internal conditions. This is
a unique property among antioxidants, as most work either in
lipid or aqueous phases, but not both. Research shows that Flavay®
can regulate nitric oxide and quench superoxide and the hydroxyl
radical. This is extremely important. Of all the free radicals
formed in the body, the hydroxyl radical is the most dangerous
because it can directly attack DNA. As a free radical scavenger,
Flavay® is like an antioxidant prize fighter that can
successfully take on all challengers, big or small, in any kind
of weather.
Statements made herein have not been
evaluated by the Food and Drug Administration. These products are not intended
to diagnose, treat, cure or prevent any disease.
Masquelier, J. A lifetime devoted to OPC and Pycnogenols. Alfa
Omega Editrice, Pub., 1996.
Schwitters, B., Masquelier, J. OPC in practice. Alfa Omega Editrice,
Publishers, 1995.
Kilham, C., Masquelier, J. OPC: The miracle antioxidant. Keats
Publishing, Inc., 1997.
Mindell, E., et al. Earl Mindell’s vitamin bible for the
21st century. Warner Books, Inc., 1999.
Passwater, R.A. The antioxidants: the nutrients that guard your
body. Keats Publishing, Inc., 1985.
Barilla, J. et al. The nutrition superbook: volume 1: the antioxidants.
Keats Publishing, Inc., 1995.
Facino RM, et al. Free radical scavenging action and anti-enzyme
activities of procyanidines from Vitis vinifera. A mechanism for
their capillary protective action. Arzneimittelforschung, 44:
592-601, 1994.
Kuttan R, et al. Collagen treated with catechin becomes resistant
to the action of mammalian collagenase. Experientia, 37: 221-223,
1981.
Masquelier, J., et al. Stabilization du collagene par les oligomeres
procyanidoliques. Acta Therapeutica, 7:101-105, 1981.
Masquelier, J. Aspects pharmacologiques nouveaux de certains flavonoides.
A Vie Medical 12:1969.
Laparra, J., et al. Etude pharmaco-cinetique des oligomers procyandoliques
totaux du raisin. Acta Therapeutica, 4, 1978.
Laparra, J., et al. Etude pharmacocinetique des oligomeres flavonoliques.
Plantes med et phyto, Tome XI, pp. 133-142, 1977.
Robert A.M.; Groult, N.; Six, C.; Robert, L. Etude de l’action
des oligomeres procyanidoliques sur des cellules mesenchymateuses
en culture. Ii l’attachment des fibres elastiques aux cellules.
(Study of the effect of procyanidolic oligomers on mesenchymal
cells in culture. Ii attachment of elastic fibers to the cells.)
Pat Biol, (30)6:601-7, 1990.
Porter, Lawrence J., Wong Rosalind Y. Chan, Bock G. The molecular
and crystal structure of (+)-2,3-trans-3,4-trans-leucocyanidin
[(2r,3s,+r)-(+)-3,3’, 4.4’, 5.7’-Hexahydroxyflavan]
dihydrate, and comparison of its heterocyclic ring conformation
in solution and the solid state. Journal of the Chemical Society;
Perkin Transactions I 1985. pp. 1413-17.
Masquelier, J. Proanthocyanidins et radicaux libres. 1985.
Uchida, S., et al. Condensed tannins scavenge active oxygen free
radicals. Med Sci Res, (15) 1987. pp. 831-832.
Ariga, T. Radical scavenging action and its mode in procyanidins
b-1 and b-3 from azuki beans to peroxyl radicals. Agric Biol Chem,
54(10) 1990. pp. 2499-2504.
Da Silva, R., et. al. Radical scavenger capacity of different
procyanidins from grape seeds. Presented at a symposium, “Free
radicals in biotechnology and medicine.” Royal Society Of
Chemistry, London January 1990, pp. 79-80.
Bauman, J., Wurm, G., Bruchhausen, F. “Hemmung der prostagladinsynthetase
durch flavonoide und phenolderivate im vergleich nit deren 02
radikalfangereigenschaften” Arch Pharm, (Weinheim) 313 (1980)
pp. 330-337.
Lombard, J., et al. The brain wellness plan. Kensington Pub. Corp.,
1998.
Braverman, E., et al. The healing nutrients within: in facts,
findings and new research. Keats, 1987.
Facino, R.M., et al. Free radical scavenging action and anti-enzyme
activities of procyanidines from vitis vinifera. A mechanism for
their capillary protective action. Arzneimittelforschung, 44:
592-601, 1994.
Kuttan, R., Donnelly, P.V., Di Ferrante, N. Collagen treated with
catechin becomes resistant to the action of mammalian collagenase.
Experientia, 37: 221-223, 1981.
Masquelier, J. Procyanidolic oligomers. J Parums Cosm Arom, 95:
89-97, 1990.
Tixier, J.M., et al. Evidence by in vivo and in vitro studies
that binding of pycnogenols to elastin affects its rate of degradation
by elastases. Biochem Pharmacol, 33: 3933-3939, 1984.
Kakegawa, H., et al. Chem. Pharm. Bull. 33:5079, 1985.
Harmand, M.F., Blanquet, P. The fate of total flavanolic oligomers
extracted from ‘vitus vinifera l.’ in the rat. European
Journal of Drug Metabolism and Pharmaccokinetics. 1978, No. 1
pp. 15-30.
Delrieu, P., Ding J., Escande, B., Samain, D. Free-radical scavenging
activity of proanthocyanidolic oligomers encapsulated in glycospheres:
an in vivo and in vitro study. Cosmetology Department & S
Biovectors, Ramonville St. Agne France. pp. 1-9.
Meunier, M.T., Villie, F., et al. Inhibition of angiotensin i
converting enzyme by flavanolic compounds: in vitro and in vivo
studies. Planta Medica, May 26, 1986. pp. 12-15.
Barbier, A., et al. Activite angioprotectrice des oligomeres procyanidolques
chez l’animal-oedenme de la patte. Sanofi Res Toul Cedex
Fr, pp31-40.
Barbier, A., et al. Activite angioprotectrice des oligomeres procyanidolques
chez l’animal-activite aniagoniste vis-a-vis des mediateurs
de l’inflamation. Sanofi Res Toul Cedex Fr, pp. 31-40.
Dubos, C., Durst, G., Hugonot, H. Evolution de la resistance capillaire,
spontanement ou artificiellement diminuee par l’action d’une
substance capillaro-toxique chez des personnes agees--action benefique
d’un agnet actif sur la micro-circulation: l’Endotelon.
Inform. Therapeut. 1980. pp. 302-305.
Dartenuc, J.Y., et al. Resistance capillaire en geriatrie etude
d’un microangioprotecteur-Endotelon. Bordeaux Med. 13:903-7,
1990.
Lagrue, G., Olivier-Martin, F., Grillot, A. “Etude des effets
des oligomeres du procyanidol sur las resistance capillaire dand
l’hypertension arterielle et certaines nephropathies.”
Sen. Hosp. Paris 18-25 Septembre, 1981.
Beylot, C., Bioulac, P. Essai therapeutique d’un angioprotecteur
peripherique, l’Endotelon. Actualite Therapeutique Gaz. Med.
de France (87)22:2919-24, 1980.
Lesbre, F.X., Tigaud, J.D. Effect de l’Endotelon sur l’indice
de fragilite capillaire dan une population specifique: les sujets
cirrhotiques. Gaz. Med. de France, (90)24 1983.
Sarrat, L. Abord therapeutique des troubles fonctionnels des membres
inferieurs par un microangioprotecteur l’Endotelon. Bordeaux
Med, 11:685-8, 1981.
Delacroix, P. Etude en double aveugle de l’Endotelon dans
l’insuffisance veineuse chronique. Therapeutique, la Revue
de Medicine, (27-28) Sept. 1981. pp. 1793-1802.
Thebaut, J.F, Thebaut, P., Vin, F. Etude de l’Endotelon dand
les manifestations fonctionnelles de l’insuffisance veineuse
peripherique-resultats d’une etude en double aveugle portant
sur 92 patients.” Gazette Medicale, (92)1, 1985. pp. 96-100.
Wegrowski, J., Robert, A.M., Maczar, M. The effect of procyanidolic
oligomers on the composition of normal and hypercholesterolemic
rabbit aortas. Biochem. Pharmacol, (33)21. 1984. pp. 3491-3497.
Chang, W.C., Hsu, F.L. Inhibition of platelet aggregation and
arachidonate metabolism in platelets by procyanidins. Prostagland
Leukotri Essent Fatty Acids, 38:181-8, 1989.
Masquelier, J. Pycnogenols: recent advances in the therapeutical
activity of procyanidins. Supplement of Planta Medica, Journal
of Medicinal Plant Research and Journal of Natural Products, July
1980 pp. 243-256.
Henning, B., et al. Lipid peroxidation and endothelial cell injury:
implications in atherosclerosis. Free Rad Path & Med, (4)1988
pp. 99-106.
Masquelier, J. “Les procyanidols du vin leur role dans l’alcoolisme.”
pp. 88-93.
Gazave, J.M. “Notions recentes sur les capillaires”
unpub. bulletin from the Laboratoire De Physiologie Patholigie
pp. 26-29.
Ruf, J.C. Wine and polyphenols related to platelet aggregation
and atherothrombosis. Office International Vigne et du Vin, Nutrition
and Health Unit, Paris France; Drugs under Experimental and Clinical
Research (Switz.) 25/2-3 (125-131), 1999.
Blaszo, G. Gabor, M. Oedema-inhibiting effect of procyanidin.
Acta Physiologica Academiae Scientiarum Hungaricae, Tomus 56(2):235-240,
1980.
Tayau, M.F, LeFevre, G. Action du leucocyanidol sur l’hyalaluronidase.
Bull Soc Pharm Bordeaux, 95:132-136, 1956.
Lamy, M. Utilization des oligomeres procyanidoliques en gynecologie.
Essai Therapeutique Tomel (14) Sept. 2, 1981. pp. 1021-22.
Henriet, J.P “Une Etude Exemplaire Pour Un Phlebotrope: l’etude
EIVE.’ Unpub., pp. 77-83.
Pfister, A., Simon, M.T., Gazave, J.M. Sites de fixation des oligomeres
procyanidoliques dans la paroi des capillaires sanguins du poumon
decobaye. Acta Therapeutica (8) 1982. pp. 223-237.
Kuttan, R., Donnelly, P., Di Ferrante, N. “Collagen treated
with (+) -catechin becomes resistant to the action of mammalian
collagenase.” Laboratory of Connective Tissue Research, Dept.
of Biochem. Baylor Col. of Med., Houston TX. 28, May, 1980.
Gendre, P., Laparra, J., Barraud, E. “Effect protecteur des
oligomeres procyanidoliques sur le lathyrisme experimental chez
le rat.” Ann. Pharm. Francaises, (43)1, 1985 pp. 61-73.
Corbe, C., Boissin, J.P., Siou, A. Light vision and chorioretinal
circulation. Study of the effect of procyanidolic oligomer (Endotelon).
Jn. Fr. Opthalmol, (11)5:453-460, 1988.
Boissin, J.P., Corbe C., Siou, A. Chorioretinal circulation and
dazzling: use of procyanidol oligomers (Endotelon). Bull Soc Ophtalmol
Fr, 88(2):173-4, 177-9, 1988.
Proto, F. et al. Electrophysical study of vitis vinifera procyanoside
oligomers effects on retinal function in myopic subjects. Ann
Ott Clin Ocul, 114:85-93, 1988.
Saracco, J.B., Estachy, G.M. Etude d l’Endotelon en opthalmologie.
Gaz Med de France, 88:2035-2038, 1981.
Scharrer, A., Ober, M. Anthocyanosides in the treatment of retinopathies.
Klin Monatsbl Augenheilkd, 178:386-389, 1981.
Corbe, C., et al. Microangiopathy of the retina. J. Fr. Opthalmol,
11:453, 1988.
Verin, M.M., Vildy, A., Maurin, J.F., Retinopathies et O.P.C.
Bordeaux Medicale, (16)11. pp. 1467-74, 1978.
Soyeux, A. et al. Endotelon. Diabetic retinopathy and hemorheology.
Bull Soc Ophtalmol Fr. 87(12):1441-4, 1987.
Fromantin, M. “Les oligomeres procyanidoliques dans le traitement
de la fragilite capillaire et de la retinopathie chez les diabetiques.
A propos de 26 cas.” Med Int, 16(11):432-434, Nov. 1981.
Arne, J.L. Contribution a l’etude des oligomeres procyanidoliques:
Endotelon, dans la retinopathie diabetique (a propos de 30 observations).
Gaz. Med. de France, Vol. 89, No. 30, Oct. 8, 1982.
Baruch, J. Effect of Endotelon in postoperative edema. Results
of a double-blind study versus placebo in 32 female patients.
Ann Chir Plast Esthet 29(4):393-5, 1984.
Rao, C.N. et al. Influence of bioflavonoids on the collagen metabolism
in rats with adjuvantinduced arthritis. Ital J Biochem. 30:54-62,
1981.
Gabor, M. Pharmacologic effects of flavonoids on blood vessels.
Angiologica, 9:355-374, 1972.
Havsteen, B. Flavonoids, a class of natural products of high pharmacological
potency. Biochem Pharmacol, 32:1141-48, 1983.
Reimann, H.J., Lorenz, W., Fischer, M., Frölich, R., Meyer,
H.J. Berkhauser Verlag, Vol. 7/1, Univ. of Marburg/Lahn, Ger.,
1977.
Masquelier, J. Action protectrice du vin sur l’ulcere gastrique.
Resultats, p. 61.
Amella, M., et al. Inhibition of mast cell histamine release by
flavonoids and bioflavonoids. Planta Medica, 5116-20, 1985.
Packer, L., et al. The antioxidant miracle: your complete plan.
John Wiley & Sons, Inc., 1999.
Shaw, R. How [Australian] PycnoGenol [MASQUELIER’s®]
Helps Sports People.
Masquelier, J. Procyanidolic oligomers (leucocyanidins). Parfums
Cosmet Arom 95:89-97, 1990.
Pecking, A., Desprez-Curely, J.P., Megret, G. Oligomers procyanidoliques
(Endotelon) dans le traitement des lymphoedemes post-therepeutiques
de members superieurs. Symposium Satellite, Congres International
d’Angiologie, Toulouse, France, 4-7 Oct. 1989.
Fahey, T.D., Pearl M. Hormonal effects of phosphatidylserine during
2 weeks of intense training. Abstract submitted to national meeting
of the Amer College of Sports Medicine, June 1998.
Monteleone, P., Maj, M., Beinat, L., Natale, M., Kemali, D. Blunting
by chronic phosphatidylserine administration of the stress-induced
activation of the hypothalamo-pituitary-adrenal axis in healthy
men. Eur J Clin Pharm 43: 385–388, 1992.
Fahey, T.D., et al. The hormonal and perceptive effects of phosphatidylserine
administration during two weeks of resistive exercise-induced
overtraining. Bio of Sport 15(3):135-44, 1998.
Laparra, J., Michaud, J. Masquelier, J. Action des oligomeres
procyanidoliques sur le cobaye carence en vitamin c. Tavaux Originaux,
University of Bordeaux, 1976.
Masquelier, J. Action comparee de divers facteurs vitaminiques
p sur l’oxydation de l’acide ascorbique par les ions
cuivriques. Bull. de la Societe de Chimie Biologique XXXIII (3-4)
1951. pp. 302-304.
Masquelier, J. Action comparee de divers facteurs vitaminiques
p sur l’acide ascorbique-oxydase. Bull. de la Societe de
Chimie Biologique XXXIII (3,4) 1951. pp.304-306
Kakegawa, H., Matsumoto, H., Endo, K., Satoh, T., Nonaka, G.,
Mishioka, I. “Inhibitory effects of tannins on hyaluronidase
activation and on the degranulation from rat mesentery mast cells.”
Chem. Pharm. Bull. 33(11)1985. 5079-5082.
Reiman, H.J., Lorenz, M., Fischer, R., Frolich, H., Meyer, J.
“Histamine and acute haemorrhagic lesions in rat gastric
mucosa: prevention of stress ulcer formulation by (+)-catechin,
an inhibitor of specific histidine decarboxylase in vitro.”
Dirkhauser Verlag,Vol. 7/1, 1977.
Pariente, J.J. Parientl-Amsellem, J. “Les oedemes post-traumatoqies
chez le sportif: essai controle de l’Endothelon.” Actualite
Therapeutique 90(3) 2/11 1983 pp. 231-235.
Masquelier, J., et al. “Flavonoids et Pycnogenols” Int
J Vit Nut Res, (49)3:307-311, 1979.
Yu, C. L. et al. Mutagenicity of proanthocyanidins. Food Chem.
Toxicol. 25(2):135-9, 1987.
Pantaleoni, G.C., Quaglino, D. Univerisity of Aquila Pharmacol-Toxicologica
Report, 1971.
Laparra, J., et al., Acta Therapeutica, 4:233, 1978.
Volkner, Wolfgang Muller, Ewald, Micronucleus assay in bone marrow
cells of the mouse with Pycnogenol. Cytotest Cell Research GmbH
& Co., projects 143010 & 143021; Feb. 1989.
Acute and chronic toxicity tests. International Bio-Research,
Inc., Hanover, Germany, 1967-1971.
Dumon, M., Michaud, J., Masquelier, J. Proanthocyanidin content
in vegetable extracts to be used in the preparation of medicines.
Bull. Soc. Pharm. Bordeaux, 129:51-65, 1990.
